HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

VAB-3 combination chemotherapy in primary mediastinal germ cell tumors.

Abstract
Ten patients with primary mediastinal nonseminomatous germ cell tumors were treated with the VAB-3 protocol. All patients with measurable disease showed tumor regression with chemotherapy, but only two had sustained partial response allowing thoracotomy and resection of residual tumor after the second induction. Both patients received additional induction therapy and one also received irradiation; they have been free of disease 41+ and 40+ months from the beginning of chemotherapy. All other patients died from the disease.
AuthorsD Vugrin, N Martini, W F Whitmore Jr, R B Golbey
JournalCancer treatment reports (Cancer Treat Rep) Vol. 66 Issue 6 Pg. 1405-7 (Jun 1982) ISSN: 0361-5960 [Print] United States
PMID6177411 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Antineoplastic Agents
  • Bleomycin
  • Chlorambucil
  • Dactinomycin
  • Vinblastine
  • Cyclophosphamide
  • Cisplatin
Topics
  • Antineoplastic Agents (administration & dosage)
  • Antineoplastic Combined Chemotherapy Protocols
  • Bleomycin (administration & dosage)
  • Chlorambucil (administration & dosage)
  • Cisplatin (administration & dosage)
  • Cyclophosphamide (administration & dosage)
  • Dactinomycin (administration & dosage)
  • Drug Administration Schedule
  • Drug Therapy, Combination
  • Humans
  • Male
  • Mediastinal Neoplasms (drug therapy)
  • Neoplasms, Germ Cell and Embryonal (drug therapy)
  • Vinblastine (administration & dosage)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: